Cardiovascular Health

Pharmacy Times® spoke with Jenine Abuzir, PharmD candidate at Chicago College of Pharmacy at Midwestern University, about her experience teaching in the Women’s Health elective during pharmacy school.

What would you recommend to these patients?

Researchers found the largest decreases for heart attack risk among women, which may be because of greater attention paid to women’s heart health in recent decades.

A new study found that hypertension is a common comorbidity in patients with COVID-19.

Top news of the week from Pharmacy Times®.

Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.

Mindfulness training may hold the key to reducing the risk of cardiovascular disease, which is rapidly becoming the leading cause of death worldwide.

Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.

Mailing educational materials to patients with atrial fibrillation and their clinicians did not increase the use of stroke prevention drugs.

Patients reported their likeness of having support from a trusted health care professional, rapid feedback, and adjustments to their treatment with someone to be accountable to, according to the study authors.

Research suggests ketogenic and intermittent fasting diets seem to help people lose weight in the short-term, which benefits cardiovascular health.

A pacemaker may help reduce or eliminate the risk of fainting in certain patients

Although the adverse effects of the lockdown were inevitable for cardiology patients, increased technology services may offer an opportunity for expanded patient access.

Despite contrary studies, new evidence indicates premenopausal women fair better after a heart attack than men.

Despite an ongoing long-term debate, no link was found between cancer and the use of ACE inhibitors, beta blockers, and other common antihypertensive drugs.

The study evaluated whether conditions such as depression in adolescence are associated with a higher risk of cardiovascular disease in adulthood.

An analysis of phase 3 study data found that 99% of patients who received inclisiran showed a significant placebo-adjusted reduction in low-density lipoprotein cholesterol (LDL-C).

Athletes and endurance athletes are at an increased risk of atrial fibrillation.

The UK Stroke Association noted that rather than focusing on fish oil, individuals should eat fresh foods low in salt and sugar, such as fruits and vegetables, and rich in fiber, such as brown varieties of bread and pasta.

Evolocumab in combination with statins and other lipid-lowering therapies was found to significantly reduce low-density lipoprotein cholesterol in pediatric patients with heterozygous familial hypercholesterolemia.

This is the first study to systematically investigate whether individual blood pressure medications might influence the risk of developing depression, according to the authors.

Women prescribed beta blockers for hypertension who have no history of cardiovascular disease have a 4.6% greater risk of heart failure than men when experiencing acute coronary syndrome.

The study findings underscore the importance of medication adherence, an issue in which pharmacists can play a major role in the patients' lives.

Patients with peripheral artery disease and depressive symptoms experience worse recovery than patients without depressive symptoms.

There is no greater support team available to students than their pharmacy school.

Symptoms of polycystic ovary syndrome, such as obesity and diabetes, can lead to a 19% higher risk of heart disease.

The death rate for patients who experienced a normally lower-risk heart attack rose sharply during the peak of the coronavirus disease 2019 pandemic.

Researchers find a link between bacterial infections and the development of late diabetic complications and coronary heart disease.

Vitamin K levels show observational relationship with risk of death in older population.

Individuals covered via high-deductible health care plans not found to have a greater risk of heart attack or stroke.